True entrepreneurs don't wait for big companies to come up with solutions - they boldly create them. This even applies to medicine.
Dr. Samir Khleif is founder and CEO of Georgiamune, a biotech company launched in 2014 that's developing drugs to boost immune responses to diseases, including cancer.
After working in traditional medical and academic settings, Dr. Khleif didn't want to wait around for Big pharma.
Biopharma is no easy industry, but Georgiamune has managed to advance its medicines toward customers and garner investments from firms like Alexandria Venture Investments, Catalog Capital Management, CJNV BioVentire, and more.
Dr. Khleif asserts that being an entrepreneur and making change sometimes means stepping up and doing the work yourself.
